Prescription drug prices in the US are roughly 2.78 times higher on average than in 33 other high-income countries, a 2024 report by the RAND Corporation found.
Opinion
Opinion
The New Republic on MSNTrump Gives Himself Untold Powers With Drug Cartel Declaration
The New York Times obtained a confidential memo sent to Congress this week that announced President Trump had “determined” that the U.S. is actively at war with drug cartels, which are now officially ...
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma ...
Two Delaware County prison inmates have been charged with dealing drugs while in the facility. Marguan Brown, 31, Philadelphia, and Antwuan Freeman, 37, Chester, have been charged by the Delaware ...
Big Pharma faces uncertainty as the Trump administration pushes MFN drug pricing and 100% tariffs on non-US manufactured patented medicines. Last night's policy announcement around a proposed 100% ...
The Louisiana Legislature didn't ban PBM vertical integration. But state leaders are still working on ways to limit to power of the pharmaceutical industry middlemen.
KALAMAZOO COUNTY, MI — Pfizer is working with the Trump administration to deliver medicine at a lower cost. The Tuesday, Sept. 30 agreement brings U.S. drug prices into line with those consumers in ...
Scripps News on MSN
FDA approves generic version of mifepristone abortion drug, sparking conservative backlash
The Food and Drug Administration this week approved a generic version of mifepristone, the drug most commonly used to terminate pregnancy during a medication-induced abortion.
The government shut down began at midnight on Wednesday as Democrats and Republicans appeared to be nowhere close to reaching a funding deal.
Two men were arrested on felony drug and weapons charges after being pulled over by Homeland Security agents for running a red light, court records show. It occurred on ...
6don MSN
Trump’s pharma tariffs could raise drug prices for consumers, but exemptions may blunt impact
In a Truth Social post late Thursday, Trump said that any branded or patented pharmaceutical products brought into the U.S. would face a 100% tariff starting Oct. 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results